NextPlat Corp (NASDAQ:NXPL) released its third-quarter operating results for the period ended September 30, 2026, disclosing significant margin improvement alongside a contraction in total consolidated revenue compared with the year-earlier period.
Key Highlights
- Consolidated revenue: Approximately $10.5 million for Q3 2026, compared with $13.8 million in Q3 2025, according to the filing.
- Pharmacy contract revenue: Increased 300% to approximately $2.4 million, up from approximately $0.6 million in the prior-year period.
- 340B prescription volumes: Grew nearly 72% year-over-year, driven by multiple new entities added since late last year.
- Overall gross margin: Approximately 35.0% in Q3 2026, compared with 19.9% in Q3 2025, described by the company as near-record levels.
- Net loss narrowed: Net loss attributable to common stockholders decreased approximately 66% to approximately $0.7 million, or ($0.28) per diluted share, versus approximately $2.2 million, or ($0.84) per diluted share, in Q3 2025.
- Cash position: Approximately $11.2 million in cash and working capital of approximately $13.5 million as of September 30, 2026, with no material unsecured debt.
- E-commerce revenue: Increased 3% to approximately $3.8 million, with sales to customers in more than 115 countries during the quarter.
NextPlat's Healthcare and E-Commerce Segments in Q3 2026
According to the filing, NextPlat Corp, which the company describes as "a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide," reported that its Healthcare Operations segment drove the most notable financial changes in the quarter. Pharmacy contract revenue, which includes 340B contracted services and medication fulfillment, reached approximately $2.4 million, a 300% increase from approximately $0.6 million in the prior-year period. The filing attributed approximately $1.6 million of this increase to growth in 340B contract revenue, broken down as approximately $1.0 million from existing contracts and approximately $0.6 million from new contracts. Pharmacy prescription revenue, by contrast, fell to approximately $4.3 million from approximately $9.5 million in Q3 2025, which the company attributed primarily to lower reimbursement rates and reduced retail prescription volumes.
Healthcare Operations gross margin reached approximately 41% in Q3 2026, a 23 percentage point improvement from 18% recorded in Q3 2025. The filing noted that three new 340B services contracts were added during the quarter, with onboarding underway and contributions expected in early 2027. On the expansion front, the company disclosed the acquisition of Scott's Pharmacy in the Pensacola area of Northwest Florida and the opening of a new Jacksonville location. The filing stated that the company "continues to explore additional selective acquisitions that could significantly increase the scale of its pharmacy network, including those potentially beyond the state of Florida."
The e-commerce segment, which the filing noted includes global satellite connectivity hardware and airtime services sold through NextPlat's UK subsidiary Global Telesat Communications Ltd (GTC), generated approximately $3.8 million in revenue, up 3% from approximately $3.7 million in Q3 2025. E-commerce gross margin remained stable year-over-year at approximately 24%. The company reported it expanded its international sales channels through Decathlon, described in the filing as "a leading international sporting-goods retailer," offering satellite connectivity products in 20 countries. Total operating expenses decreased to approximately $4.5 million from approximately $4.9 million in Q3 2025, the filing disclosed, citing lower salaries, wages, and payroll taxes, and a reduction in litigation settlement losses.
What Was Disclosed
NextPlat Corp disclosed its Q3 2026 operating results in a press release dated November 12, 2026, covering the quarter ended September 30, 2026. The filing reported lower consolidated revenue but meaningfully improved gross margins and a significantly reduced net loss compared with the prior-year quarter.




Please wait processing your request...